Article Detail - JE Part A
Billing and Coding: Nerve Blockade for Treatment of Chronic Pain and Neuropathy (A56034) - R11 - Effective March 5, 2026
Date Posted: March 12, 2026
This Billing and Coding Article has been revised under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Effective Date: March 5, 2026
Summary of Changes:
Under Article Text, revised the sentence from "The use of peripheral nerve blocks for treating diabetic neuropathy is not considered reasonable and/or necessary and is not covered by Medicare Part A or B." to "The use of peripheral nerve blocks for treating metabolic peripheral neuropathy is not considered reasonable and/or necessary and is not covered by Medicare Part A or B."
Visit the Noridian Active LCDs webpage to view the document or access it via the CMS Medicare Coverage Database (MCD).